StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 1/30
$17.49−0.50 (-2.78%)

Close on Nov 13, 2026Market cap $1.27BP/E –Yield –

Omeros profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Omeros's profit margin for the twelve months ending Mar 31, 2021 was -202.0%. For fiscal 2020 it was -187.0%, against -75.6% the year before. The highest annual figure on record is -75.6% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-187.0%−111.5
FY2019Dec 31, 2019-75.6%+348.8
FY2018Dec 31, 2018-424.4%−341.9
FY2017Dec 31, 2017-82.5%+77.9
FY2016Dec 31, 2016-160.4%+395.5
FY2015Dec 31, 2015-555.9%+13112.6
FY2014Dec 31, 2014-13668.5%−11181.2
FY2013Dec 31, 2013-2487.3%−1848.9
FY2012Dec 31, 2012-638.4%−7.4
FY2011Dec 31, 2011-631.0%+758.6
FY2010Dec 31, 2010-1389.6%+70.9
FY2009Dec 31, 2009-1460.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202646.4%+193.7
Q1 FY2026Mar 31, 2026566.7%+812.7
Q1 FY2021Mar 31, 2021-166.6%−43.3
Q4 FY2020Dec 31, 2020-350.6%−263.1
Q3 FY2020Sep 30, 2020-147.3%−92.1
Q2 FY2020Jun 30, 2020-246.1%−192.1
Q1 FY2020Mar 31, 2020-123.3%−11.6
Q4 FY2019Dec 31, 2019-87.5%+19.4
Q3 FY2019Sep 30, 2019-55.1%+801.5
Q2 FY2019Jun 30, 2019-54.0%+1982.0
Q1 FY2019Mar 31, 2019-111.8%+1780.8
Q4 FY2018Dec 31, 2018-106.9%+13.4
Q3 FY2018Sep 30, 2018-856.6%−822.1
Q2 FY2018Jun 30, 2018-2036.0%−1952.3
Q1 FY2018Mar 31, 2018-1892.6%−1769.5
Q4 FY2017Dec 31, 2017-120.3%+31.8
Q3 FY2017Sep 30, 2017-34.5%+89.1
Q2 FY2017Jun 30, 2017-83.7%+42.3
Q1 FY2017Mar 31, 2017-123.1%–
Q4 FY2016Dec 31, 2016-152.1%–
Q3 FY2016Sep 30, 2016-123.7%–
Q2 FY2016Jun 30, 2016-126.1%–

More Omeros figures

See a number that looks wrong?